Cystic Fibrosis Research Advances
Cystic Fibrosis Research Advances is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 30k research works in it since 1950. 20.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers encompasses a wide range of topics related to cystic fibrosis, including therapeutic interventions, pulmonary infections, bronchiectasis, primary ciliary dyskinesia, mutation analysis, lung disease, microbiota, and nutrition management. The papers cover advancements in understanding the genetic and molecular basis of cystic fibrosis, as well as the development of novel treatments and management strategies.
- Cystic Fibrosis
- CFTR
- Pulmonary Infections
- Bronchiectasis
- Primary Ciliary Dyskinesia
- Mutation Analysis
- Lung Disease
- Microbiota
- Nutrition Management
- Therapeutic Interventions
- Research works
- 30k fractional, since 1950
- In the world top 10%
- 6.2k per year above
- Top-10% rate
- 20.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +33% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cystic Fibrosis Research Advances research?
By volume, the United States and the United Kingdom publish the most (1.6k and 697 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.6k works
- 2 United Kingdom 697 works
- 3 China 345 works
- 4 Italy 336 works
- 5 Germany 279 works
- 6 France 241 works
- 7 Australia 205 works
- 8 Canada 204 works
- 9 Türkiye 181 works
- 10 Spain 174 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cystic Fibrosis Research Advances research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Cystic Fibrosis Research Advances research, followed by University of Alabama at Birmingham and University of Washington.
By volume, 2022–2025
- 1 University of North Carolina at Chapel Hill United States 71 works
- 2 University of Alabama at Birmingham United States 51 works
- 3 University of Washington United States 35 works
- 4 Emory University United States 32 works
- 5 Hacettepe University Türkiye 32 works
- 6 Cystic Fibrosis Foundation United States 30 works
- 7 Research Centre for Medical Genetics Russia 29 works
- 8 Royal Brompton Hospital United Kingdom 27 works
- 9 Cystic Fibrosis Trust United Kingdom 27 works
- 10 Inserm France 26 works
Who are the leading researchers in Cystic Fibrosis Research Advances?
The most-cited researchers publishing on Cystic Fibrosis Research Advances include Guido Kroemer, Kai Wang and Elizabeth A. Cromwell.
- 1 Guido Kroemer 4.2k citations
- 2 Kai Wang 3.1k citations
- 3 Elizabeth A. Cromwell 3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cystic Fibrosis Research Advances research done?
The largest centres of Cystic Fibrosis Research Advances research in 2022–2025 are London (United Kingdom), Paris (France), Moscow (Russia) and Chapel Hill (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Verona, Dundee and Birmingham.
Largest cities, 2022–2025
- 1 London United Kingdom 178 works
- 2 Paris France 110 works
- 3 Moscow Russia 85 works
- 4 Chapel Hill United States 75 works
- 5 Toronto Canada 70 works
- 6 Ankara Türkiye 63 works
- 7 Milan Italy 62 works
- 8 Boston United States 61 works
- 9 Seattle United States 58 works
- 10 Birmingham United States 58 works
Where it is the local speciality
- VeronaIT · 31.0 works20×
- DundeeGB · 24.1 works18×
- BirminghamUS · 58.5 works18×
- GiessenDE · 29.1 works14×
Location quotient: how much more of its research is in Cystic Fibrosis Research Advances than the world average.
Where is the best place to study Cystic Fibrosis Research Advances?
Among universities, judged by research, University of Dundee, University of Alabama at Birmingham and Emory University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Dundee United Kingdom | 65.2 | 19.8% | 18.8× | 16 | +286.5% |
| 2 | University of Alabama at Birmingham United States | 59.0 | 14.8% | 18.4× | 51 | +32.8% |
| 3 | Emory University United States | 55.1 | 16.8% | 7.9× | 32 | +106.9% |
| 4 | Dartmouth College United States | 55.1 | 29.2% | 9.9× | 11 | -9.4% |
| 5 | Hacettepe University Türkiye | 55.0 | 2.3% | 10.8× | 32 | +203.3% |
| 6 | University of Colorado Denver United States | 54.6 | 17.8% | 13.6× | 25 | +21.3% |
| 7 | University of Milan Italy | 53.9 | 16.4% | 6.8× | 25 | +155.0% |
| 8 | Medizinische Hochschule Hannover Germany | 51.3 | 16.9% | 16.1× | 20 | -0.4% |
| 9 | University of Iowa United States | 50.1 | 19.8% | 8.8× | 22 | +3.5% |
| 10 | Marmara University Türkiye | 49.9 | 11.2% | 11.6× | 24 | +48.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cystic Fibrosis Research Advances research growing?
Output in 2018–2022 was 33% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cystic Fibrosis Research Advances.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.